LONDON--(BUSINESS WIRE)--Epsilogen, a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, notes the publication today of the final phase I data from the first ever ...

The “Open Data for Data Users” e-learning course is designed to provide a broad overview of Open Data from a user standpoint, and empower anyone to take full advantage of Open Data. Open Data is a ...

WATERTOWN, Mass.--(BUSINESS WIRE)--Seismic Therapeutic, Inc., the machine learning immunology company, today announced the presentation of preclinical data for its immunoglobulin E (IgE) protease, ...

Data is presented at the 2025 American Academy of Allergy, Asthma and Immunology (AAAAI) / World Allergy Organization (WAO) Joint Congress "We believe we are at the forefront of an emerging field to ...